bovnews5h
Why Did Vincerx Pharma Inc (VINC) Stock Plunge -29.98% Last Week?
On Wednesday, Vincerx Pharma Inc (VINC) stock saw a decline, ending the day at $1.56 which represents a decrease of $-0.09 or -5.45% from the prior close of $1.65. The stock opened at $1.97 and ...
Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqory’s TROP2 Antibody Drug Conjugate, OQY-3258
Companies also provide insights into proposed strategic mergerSAN MATEO, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Vincerx ...
Vincerx Pharma and Oqory reveal merger and cancer drug data
SAN MATEO, Calif. - Vincerx Pharma, Inc. (NASDAQ:VINC), a clinical-stage biopharmaceutical company with a current market capitalization of $2.77 million, and Oqory, Inc. announced promising results ...
Palo Alto's Vincerx Pharma plans reverse stock split amid merger plans
The company has already cut its workforce, seen a leadership change and agreed to be acquired. Here's what's next.
Vincerx Pharma, Inc. Announces Reverse Stock Split
Vincerx’s Common Stock to Begin Trading on a Split-adjusted Basis on January 28, 2025SAN MATEO, Calif., Jan. 23, 2025 (GLOBE ...
bovnews2d
Vincerx Pharma Inc (VINC) Stock: Analyzing Its Quiet Power
In terms of valuation, Vincerx Pharma Inc’s market capitalization stands at $3.62 million. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market ...
Vincerx Pharma board aproves 1-for-20 reverse stock split
Vincerx Pharma (VINC) announced that its board of directors approved a 1-for-20 reverse stock split of its issued shares of common stock, which ...
Vincerx Pharma enters at-the-market equity offering deal
Vincerx Pharma, Inc. (NASDAQ:VINC), a pharmaceutical company, announced today an agreement with H.C. Wainwright & Co., LLC to sell up to $30 million of its common stock in an at-the-market equity ...
Nasdaq1mon
Vincerx Pharma, Inc. Announces Proposed Merger with Oqory, Inc.
Vincerx Pharma, Inc. has announced a proposed merger with Oqory, Inc., a clinical-stage company developing antibody-drug conjugates (ADCs) for various cancer types. After the merger, Oqory's ...
MarketWatch1mon
Vincerx Pharma To Be Acquired by Private Biotech, Cut Headcount
Vincerx Pharma said it had agreed to merge with private biotechnology company Oqory after a review of strategic alternatives. The biotech company said that it would also implement cost-cutting ...
Vincerx Pharma files $100M mixed securities shelf
EST Vincerx Pharma (VINC) files $100M mixed securities shelfInvest with Confidence: Follow TipRanks' Top Wall Street Analysts to uncover ...
Nasdaq1mon
Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.
PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through ...